Prospective observational study of cancer-associated thrombosis in patients with newly diagnosed biliary tract cancer

Prospective observational study of cancer-associated thrombosis in patients with newly diagnosed biliary tract cancer - Prospective observational study of cancer-associated thrombosis in patients with newly diagnosed biliary tract cancer

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000048891

Enrollment

Registered

2022-09-09

Start date

2022-09-09

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

biliary tract cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. informed consent in writing given freely. 2. 20 years old or older at written informed consent. 3. patients with newly diagnosed biliary tract cancer. 4. patients with a definitive diagnosis of biliary tract cancer pathologically

Exclusion criteria

Exclusion criteria: 1. patients with serious complications in other organs. 2. patients with postoperative recurrence of biliary tract cancer. 3. patients who are inappropriate as a subject of the study judged by the treating physicians.

Design outcomes

Primary

Measure	Time frame
the incidence of cancer-associated thrombosis during the observation period	—

Secondary

Measure	Time frame
1. the risk factor of cancer-associated thrombosis 2. thrombosis improvement rate and complication rate by anticoagulant therapy for cancer-associated thrombosis 3. overall survival 4. progression-free survival	—

Countries

Japan

Contacts

Public ContactYutaka Akimoto

Japanese Red Cross Okayama Hospital Gastroenterology

qttsp974@gmail.com086-222-8811

Outcome results